|
Volumn 101, Issue 3, 2000, Pages 173-175
|
Placebo revisited
a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
NEUROLEPTIC AGENT;
PLACEBO;
CLINICAL TRIAL;
DISEASE COURSE;
DRUG EFFECT;
DRUG EFFICACY;
EDITORIAL;
HUMAN;
INFORMED CONSENT;
MEDICAL ETHICS;
META ANALYSIS;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
BIOMEDICAL AND BEHAVIORAL RESEARCH;
MENTAL HEALTH THERAPIES;
ADOLESCENT;
ADULT;
ANTIPSYCHOTIC AGENTS;
CHLORPROMAZINE;
DIBENZOTHIEPINS;
DOUBLE-BLIND METHOD;
ETHICS, MEDICAL;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
PLACEBOS;
SCHIZOPHRENIA;
|
EID: 0033961310
PISSN: 0001690X
EISSN: None
Source Type: Journal
DOI: 10.1034/j.1600-0447.2000.101003173.x Document Type: Editorial |
Times cited : (4)
|
References (6)
|